Literature DB >> 26286914

Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients.

Jennifer M Knight1, J Douglas Rizzo2, Brent R Logan2, Tao Wang2, Jesusa M G Arevalo3, Jeffrey Ma3, Steve W Cole3.   

Abstract

PURPOSE: Low socioeconomic status (SES) is associated with adverse outcomes among unrelated donor hematopoietic stem cell transplant (HCT) recipients, but the biologic mechanisms contributing to this health disparity are poorly understood. Therefore, we examined whether social environment affects expression of a stress-related gene expression profile known as the conserved transcriptional response to adversity (CTRA), which involves upregulation of proinflammatory genes and downregulation of genes involved in type I IFN response and antibody synthesis. EXPERIMENTAL
DESIGN: We compared pretransplant leukocyte CTRA gene expression between a group of 78 high versus low SES recipients of unrelated donor HCT for acute myelogenous leukemia in first remission. Post hoc exploratory analyses also evaluated whether CTRA gene expression was associated with poor clinical outcomes.
RESULTS: Peripheral blood mononuclear cells collected pre-HCT from low SES individuals demonstrated significant CTRA upregulation compared with matched HCT recipients of high SES. Promoter-based bioinformatics implicated distinct patterns of transcription factor activity, including increased CREB signaling and decreased IRF and GR signaling. High expression of the CTRA gene profile was also associated with increased relapse risk and decreased leukemia-free survival.
CONCLUSIONS: Low SES is associated with increased expression of the CTRA gene profile, and CTRA gene expression is associated with adverse HCT clinical outcomes. These findings provide a biologic framework within which to understand how social environmental conditions may influence immune function and clinical outcomes in allogeneic HCT. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26286914      PMCID: PMC4703514          DOI: 10.1158/1078-0432.CCR-15-1344

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  45 in total

1.  Treatment with β-blockers and reduced disease progression in patients with thick melanoma.

Authors:  Vincenzo De Giorgi; Marta Grazzini; Sara Gandini; Silvia Benemei; Torello Lotti; Niccolò Marchionni; Pierangelo Geppetti
Journal:  Arch Intern Med       Date:  2011-04-25

Review 2.  Social isolation and health, with an emphasis on underlying mechanisms.

Authors:  John T Cacioppo; Louise C Hawkley
Journal:  Perspect Biol Med       Date:  2003       Impact factor: 1.416

Review 3.  Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

Authors:  K M Sullivan; E Agura; C Anasetti; F Appelbaum; C Badger; S Bearman; K Erickson; M Flowers; J Hansen; T Loughran
Journal:  Semin Hematol       Date:  1991-07       Impact factor: 3.851

4.  The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease.

Authors:  J Tanaka; M Imamura; M Kasai; S Hashino; S Kobayashi; S Noto; T Higa; K Sakurada; M Asaka
Journal:  Bone Marrow Transplant       Date:  1997-03       Impact factor: 5.483

Review 5.  Molecular pathways: beta-adrenergic signaling in cancer.

Authors:  Steven W Cole; Anil K Sood
Journal:  Clin Cancer Res       Date:  2011-12-20       Impact factor: 12.531

6.  Cyclosporin A/alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplant for chronic myeloid leukaemia: a clinico-pathological study.

Authors:  S H Lim; S Coleman; A Bull; U O'Callaghan; R Evely; M Booth
Journal:  Bone Marrow Transplant       Date:  1997-07       Impact factor: 5.483

Review 7.  Stress, depression, the immune system, and cancer.

Authors:  Edna Maria Vissoci Reiche; Sandra Odebrecht Vargas Nunes; Helena Kaminami Morimoto
Journal:  Lancet Oncol       Date:  2004-10       Impact factor: 41.316

8.  Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor.

Authors:  E Fietze; S Prösch; P Reinke; J Stein; W D Döcke; G Staffa; S Löning; S Devaux; F Emmrich; R von Baehr
Journal:  Transplantation       Date:  1994-09-27       Impact factor: 4.939

Review 9.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

10.  Elevated inflammatory cytokine levels in bone marrow graft rejection.

Authors:  A Nagler; R Or; B Nisman; I Kalickman; S Slavin; V Barak
Journal:  Transplantation       Date:  1995-11-15       Impact factor: 4.939

View more
  37 in total

Review 1.  Emotion and biological health: the socio-cultural moderation.

Authors:  Shinobu Kitayama; Jiyoung Park
Journal:  Curr Opin Psychol       Date:  2017-07-05

Review 2.  The impact of psychosocial stress and stress management on immune responses in patients with cancer.

Authors:  Michael H Antoni; Firdaus S Dhabhar
Journal:  Cancer       Date:  2019-02-15       Impact factor: 6.860

3.  Is It Better to Be Rich or Relaxed? Sociobiology Meets Bone Marrow Transplant.

Authors:  Lucie M Turcotte; Michael R Verneris
Journal:  Clin Cancer Res       Date:  2015-10-19       Impact factor: 12.531

4.  Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial.

Authors:  Jennifer M Knight; J Douglas Rizzo; Parameswaran Hari; Marcelo C Pasquini; Karen E Giles; Anita D'Souza; Brent R Logan; Mehdi Hamadani; Saurabh Chhabra; Binod Dhakal; Nirav Shah; Deepika Sriram; Mary M Horowitz; Steve W Cole
Journal:  Blood Adv       Date:  2020-02-11

5.  Opportunities and challenges of big data for the social sciences: The case of genomic data.

Authors:  Hexuan Liu; Guang Guo
Journal:  Soc Sci Res       Date:  2016-04-21

6.  Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Sagar S Patel; Lisa A Rybicki; Donna Corrigan; Brian Bolwell; Robert Dean; Hien Liu; Aaron T Gerds; Rabi Hanna; Brian Hill; Deepa Jagadeesh; Matt Kalaycio; Brad Pohlman; Ronald Sobecks; Navneet S Majhail; Betty K Hamilton
Journal:  Biol Blood Marrow Transplant       Date:  2018-01-31       Impact factor: 5.742

7.  Social well-being is associated with less pro-inflammatory and pro-metastatic leukocyte gene expression in women after surgery for breast cancer.

Authors:  Devika R Jutagir; Bonnie B Blomberg; Charles S Carver; Suzanne C Lechner; Kiara R Timpano; Laura C Bouchard; Lisa M Gudenkauf; Jamie M Jacobs; Alain Diaz; Susan K Lutgendorf; Steve W Cole; Aaron S Heller; Michael H Antoni
Journal:  Breast Cancer Res Treat       Date:  2017-05-30       Impact factor: 4.872

8.  Positive mental well-being and immune transcriptional profiles in highly involved videogame players.

Authors:  Jeffrey G Snodgrass; Michael G Lacy; H J François Dengah; Evan R Polzer; Robert J Else; Jesusa M G Arevalo; Steven W Cole
Journal:  Brain Behav Immun       Date:  2019-07-31       Impact factor: 7.217

9.  Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes.

Authors:  Lucie M Turcotte; Tao Wang; Michael T Hemmer; Stephen R Spellman; Mukta Arora; Ashley Yingst; Daniel Couriel; Amin Alousi; Joseph Pidala; Jennifer M Knight; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2018-08-23       Impact factor: 5.742

10.  Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial.

Authors:  Jennifer M Knight; Karen L Syrjala; Navneet S Majhail; Michael Martens; Jennifer Le-Rademacher; Brent R Logan; Stephanie J Lee; Paul B Jacobsen; William A Wood; Heather S L Jim; John R Wingard; Mary M Horowitz; Muneer H Abidi; Mingwei Fei; Laura Rawls; J Douglas Rizzo
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-23       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.